Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-19-0204
Abstract: Viral-based chimeric antigen receptor-engineered T (CAR T)–cell manufacturing has potential safety risks and relatively high costs. The nonviral minicircle DNA (mcDNA) is safer for patients, cheaper to produce, and may be a more suitable technique…
read more here.
Keywords:
car cells;
dna engineered;
minicircle dna;
engineered car ... See more keywords